DatasetName,GPKOW_S(115) GPKOW_S(20) GPKOW_S(251) GPKOW_S(329) GPKOW_S(347) GPKOW_S(35) GPKOW_T(216),GPKOW_S(148) GPKOW_S(197) GPKOW_S(388) GPKOW_S(42) GPKOW_T(138)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,,
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,0.5753121466009528
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,,0.607849712174345
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,,0.6248719568275753
RKK2015_TNF-α/basal,,0.590761415776622
JJ2018_Ratio H/M normalized pP2,0.45524152965144543,0.6221057297720747
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,,
HS2024_6_B_T3,,0.5868245544939421
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,0.6058088196913912
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,,
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,0.4655426160587703,0.587820147967115
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,0.48152913909511946,
FSO2013_Ratio M/L normalized Rep1___1,,
SAS2015_AZD/DMSO_Exp3,0.48431716099975064,0.5970165026769274
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,0.463334664516258,0.6243160929531457
WZ2023_Pu_010_30min,0.42998495872444764,0.6129562151777967
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,0.4641548245389197,0.6358593661871292
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,,
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,,0.6480804189680616
JJ2018_Ratio H/L normalized___1,0.4836224030304931,0.5934682317943315
ZQ2022_C2,,
RB2022_5_PreSprint,,
PG2020_Intensity 8h_C,,
AH2018_SILAC_MR_2_N,0.4838017953221218,0.6381222946320042
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,0.6041997164598878
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,0.47151727753316147,
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,0.6583165526340957
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,0.5209207949280936,0.6046389712585527
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,
GF2025_P6_Sph,,0.626769405961662
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.46001954343586193,0.6136450555115094
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,
KBE2022_Log2_Ex_34_U,0.46356041285876165,0.5996182672676222
WZ2023_Pu_005_10min,,0.610924135687296
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,,0.5823513463167223
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,0.43989586222292215,0.6115056557272043
AH2018_SILAC_MR_2_X,0.4586870292749447,0.6420232578013174
HS2024_4_PD_T2,0.492920357034243,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,,0.6277791553056706
FR2021_Norm.Intensity.B,,0.5788336997767033
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,0.4678096183403585,0.6334996516957868
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,,
CR2017_Ratio Replicate 1.3,,0.6304121280889738
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,,0.6334926417346606
JJ2018_Ratio M/L normalized pP3,0.4818467376793037,0.6164433285835055
AH2018_SILAC_M_2_N,,0.6336228340646228
HS2024_7_PD_T2,0.47260335394983155,
FSO2013_Ratio H/L normalized Rep1___1,,0.6352541442780196
AH2018_LFQ_1_C,,0.6332075813203503
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,,
HS2024_3_B_N1,,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.45460572542384553,0.6124691449437493
CK2022_11 40-1,,0.5818342897052589
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,,0.6328299015897851
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,,0.6048036196846445
FSO2013_Ratio H/L normalized Rep2,,0.6056265615046555
WZ2023_Pu_005_20min,,0.6127953785401065
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,,0.6115373935650957
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,0.46485192805593406,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,0.46126753153998123,0.637171323734952
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,,0.5995507758884954
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,0.47146548483786344,0.6370537265686963
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,,
FR2021_Norm.Intensity.H,,0.5844730351228844
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,0.4774613387265431,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,,0.6002726280815376
CK2022_1 200-1,0.4674699393608642,0.6143921764047221
PG2020_Intensity Mock_10h_D,,
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,0.46905200185886614,0.6410174153931955
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.5148191629081987,0.6904699281662563
RCJD2014_5min_1,,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,0.4703482456283199,0.627133590740721
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,0.48595531616895066,0.6023272443000685
CR2017_Ratio Replicate 3.3,,0.6030392204319165
PG2020_Intensity 2h_C,,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,,
KBE2022_Log2_Ex_8_T,,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,0.48835344945592674,0.6445095604482722
RN2012_L11,,0.6041993103544495
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,0.6080557891952919
HS2024_5_PD_T1,0.472400195560437,
AH2018_LFQ_M_2_C,,0.6490249521060957
CK2022_3 40-1,,0.5827803817205812
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,0.47599315298988437,
YA2020_Reporter_intensity_Cancer_No.5,,0.6151877287624732
HH2022_Reporter intensity 8,,
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,0.4762140839903561,0.6352266010023525
EJN2021_5_Rest_Basal,,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,0.5579301284495392
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,,0.6339917550433491
YA2020_Reporter_intensity_Normal_No.1,,0.6105831838948349
HS2024_3_B_T1,0.484752787061635,0.5971360011284423
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,0.5750942176588408
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,0.49327092869886524,0.6120797897866501
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,,0.6296899322920437
HS2024_8_I_T3,0.48570355880000743,
CF2017_EOC 3,,0.5883482646685431
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,0.45671157514866045,0.6080631448732822
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.4522592750561056,0.6125116223507202
AS2011_Ratio H/L_3,,
CK2022_1 40-1,,0.5853584188538445
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,,0.6100699809029873
KS2014_Intensity N3,0.4676688560737131,0.6448662193400102
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,,0.6275191655509738
FSO2013_Ratio H/M normalized Rep2,,0.5894894330521236
RAM2015_Log2 A,0.4574851881175084,0.6080488724767331
HS2024_8_PD_T1,0.4840829146499671,
JJ2018_Ratio H/L normalized pP2,0.4829371326087425,0.601138596189326
CF2017_OSE 27,,
KS2014_Intensity E15_2,0.4600273439756944,0.6025394670813964
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,,
HS2024_7_I_T1,0.4694097620480712,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,0.6139720105024077
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,
AH2018_SILAC_M_3_X,,0.6338276796981342
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,0.46747908903554675,0.6280293501913292
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,,0.6332755880425813
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.4639595565036722,0.6253402258613437
HS2024_6_B_N1,,
KBE2022_Log2_Ex_27_T,0.460839597175625,0.5888554843902485
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,0.6090175803057438
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,
AH2018_SILAC_IT_3_X,,0.6373370141331952
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,,
FSO2013_Ratio M/L normalized Rep2,,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,,
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,,0.5864603766001648
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,,0.5283234179036173
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,,0.6369843202552246
DL2023_control-1,,
AR2021_ALG 10 μM,,0.6233785423491484
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,,0.638571747179691
EJN2021_4_Rest_Ins,,
RN2012_H05,,0.5951429999119962
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,,
HH2022_Reporter intensity 3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,,0.6278082044140149
JW2021_After_3,,
GF2025_P8_Sph,,0.6405843150019997
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,0.49428434647417857,0.5955198639965232
AH2018_SILAC_2_N,,0.6335230094812172
CK2022_11 200-1,0.46343179988075883,0.6170195886792493
CK2022_12 200-1,0.46234274321225816,0.6127558895651012
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,,
WZ2023_Su_010_20min,0.45387218814287816,0.6128228691401135
AH2018_TMTMS2_2_N,0.47239611855714514,0.6491829740877437
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,0.46562297852634915,0.5971887827147542
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,
AH2018_TMTMS3_Pool,0.4662219775607515,0.623751662011505
KS2014_Intensity N4,0.4846121392642781,0.6421786444127323
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,0.6345143548307673
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,,
CK2022_14 200-1,0.4652214441154961,0.6139171310254263
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,0.4630908678136055,0.6127724993721395
AST2020_anti-CD3+PDL2.2,,
PG2020_Intensity Mock_10h_A,,0.56062521186954
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,,0.6109789567180286
GF2025_P1_Adh,,
GF2025_P1_Sph,,
EJN2021_5_Ex_Basal,,
HS2024_7_I_T3,0.462268332955253,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.46545478607250607,0.6126342521652101
CF2017_EOC 1,,0.5932332113706863
CK2022_3 200-1,0.46826698707175207,0.6142846299004776
AH2018_LFQ_IT_3_C,,0.630771633931863
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,0.6561152747100658
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,0.5061445425114318,0.5739366467417218
HS2024_5_B_T1,0.4918096355742919,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,,
RB2022_6_PreStrength,,
CK2022_2 40-1,,0.5884216928304636
RB2022_1_PostSprint,,
CK2022_4 200-1,0.4682867340294944,0.6138813195086554
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,,0.6081294181994983
AR2021_ALG 1 μM,,0.6052199453909254
HS2024_4_B_T1,0.47861760529020897,
MV2014_Ratio M/H normalized A3___1 (10 min),,0.5937563679668234
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,
CR2017_Ratio Replicate 3.2,,0.6013615298490591
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,,0.640429540430115
CK2022_9 16-1,,0.604909367941368
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,0.46359356788554823,0.615186840229437
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,,
CK2022_16 16-1,,0.6142213677512345
FS2019_db/db3,,
CK2022_15 40-1,,0.5902438351168725
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,,0.6136944194017498
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,0.4614901312941357,0.5936483213394979
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,,0.6327318587769335
HS2024_5_PD_T3,,0.610612699598619
AH2018_TMTMS3_3_X,0.46723778147072803,0.6330216728095447
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,,
AH2018_LFQ_M_1_N,0.45466194121908365,0.6341543887444976
KBE2022_Log2_Ex_27_U,0.462381835989245,0.5920316247027501
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,0.5951654855134888
AH2018_SILAC_M_1_N,,0.6279790637287119
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,,0.6096153328081405
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,,0.5685537950983806
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,0.5960983655809962
CK2022_12 16-1,,0.6086939954069619
RN2012_L13,,0.6095643343260541
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,,
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,0.4662295066885069,0.6633551838649969
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,0.4826074285751226,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,,0.5929591782595804
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,,0.5794890643938306
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,0.46958452778654314,
HH2022_Reporter intensity 6,,
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,0.4795091423566152,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,,0.656238575365079
GF2025_P3_Adh,,
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,0.474724044158216,0.6448629592084354
RM2024_Intensity D0-1___2,,0.5787606248365326
LY2019_P4+,0.48567746926502714,
KBE2022_Log2_Ex_19_U,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,,0.6133276222235692
AST2020_Control,,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,,
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,,
RB2022_7_RecoverySprint,,
YA2020_Reporter_intensity_Normal_No.3,,0.6035772202458037
HS2024_8_B_T2,0.4747226487543464,
AH2018_LFQ_1_X,0.456419660276095,0.6316840295887448
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,
FR2021_Norm.Intensity.M,,0.5818133381304943
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.46984215375986793,0.6435748111453281
HH2022_Reporter intensity 1,,
HH2022_Reporter intensity 2,,
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,0.5838960382879365
YA2020_Reporter_intensity_Normal_No.5,,0.6103812832765427
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,0.6079998477433306
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.44107836322863114,0.5304873723988848
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,0.44512682568933365,0.6120484029220403
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,,0.6119525047401447
AR2021_KD 72h,,0.6225159229028338
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,0.4621571033289285,0.5869866966046524
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,0.47013059564216103,0.6238437021722085
KBE2022_Log2_Ex_9_U,0.4641181962216828,0.605586897907294
AH2018_SILAC_M_3_N,,0.6340786976245893
KBE2022_Log2_Ex_13_T,,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,,
CF2017_OSE 29,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,0.4868316266367557,
PG2020_Intensity 10h_A,,
RN2012_L12,,0.5944673470769057
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,,0.6303052695984026
SAS2015_PLX/AZD_Exp1,0.478064663147239,0.626930590407838
FR2021_Norm.Intensity.A,,0.57658547087032
FSO2013_Ratio H/M normalized Rep1___1,,0.6054336290807386
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,0.657350291813786
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,,0.5879559337888838
RB2022_7_RecoveryEndurance,,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,
TM2022_S2.12h.B,,
RN2012_L15,0.4814406839934121,0.5964029115804126
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,,
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,0.4657500032577042,0.5975584824990732
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.4691120766964847,0.6101686894329548
RB2022_1_PreSprint,,
HS2024_4_I_N1,0.4684713703926454,
CK2022_7 200-1,0.4686197904135136,0.6140832598639953
CK2022_5 200-1,0.46824004907213373,0.6170980088030774
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,,0.6057470186671761
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,,0.6452871076428481
AH2018_SILAC_MR_1_X,0.48188106593710434,0.6384429545007488
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,0.6077506979339512
RM2024_Intensity D4-1,,0.579950437325637
KBE2022_Log2_Ex_25_U,0.4615281124787267,0.5921074216418818
AH2018_SILAC_3_C,,0.630341848257161
EJN2021_5_Rest_Ins,,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,,0.6029576161433233
CK2022_4 16-1,,0.6063118732311988
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,,
SAS2015_PLX/DMSO_Exp1,0.47903965293797246,0.6108694599316766
SFR2015_HL_log2_ratio_avg_c,0.48052102214064213,0.5303163317201858
JJ2018_Ratio M/L normalized pP2,0.49436351480608237,0.5954627682781434
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,,
FSO2013_Ratio H/L normalized Rep3,,0.5896433978716851
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,0.5872356433187382
JJ2018_Ratio M/L normalized,0.48502446255132625,0.5995785591840967
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,
KBE2022_Log2_Ex_9_T,0.4620537067837373,0.5954719018361659
AH2018_SILAC_IT_2_N,,0.6381212126990775
AH2018_SILAC_IT_1_X,,0.6349725494549092
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,0.4760010916329775,
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,,0.6310996646717534
WZ2023_Pe_025_20min,0.46005891358955137,0.6133449702353
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,0.468001092804663,
HS2024_4_I_N2,0.4729762226762619,
AH2018_TMTMS2_3_N,0.47308975715925233,0.6568989978461801
RN2012_H06,0.46581644369005765,0.5779733894606274
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,0.4786909758993402,
WZ2023_Su_005_30min,0.4434620401732123,0.6127122651351844
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.47296194146038817,0.6174096311159002
WZ2023_Su_025_10min,0.44987888247710783,0.6152840412083849
AH2018_LFQ_IT_4_X,,0.6334537135161603
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,,0.6133728937741099
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,0.44777106679300094,0.5883986591931192
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,0.5217042387508594,0.5781961741261961
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,0.4745350421141798,0.6363280232954798
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,,
LY2019_P7+,0.4774561110389434,
EP2017_Untreated R#1 normalized log2 ratio,0.48850495693616924,0.5212135278542994
RN2012_L10,,0.6138248396173479
PG2020_Intensity 4h_C,,
EP2017_Mitotic R#3 normalized log2 ratio,0.5278223525513402,0.7174320497819305
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,0.4641715871602535,0.5954221784743268
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,,0.6367701401737044
HS2024_4_B_T3,0.4852522412181184,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,0.593145755952823
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,0.4830355757123538,0.601131792816654
HS2024_8_I_T2,,0.5693097520256571
KBE2022_Log2_Ex_6_U,,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,0.46173607138463885,0.6056498808936173
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.46430934518958905,0.6162248262705179
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.5385084873073012,0.7088352723885488
GF2025_P9_Sph,,0.6266272176644156
CK2022_6 200-1,0.4689364598799851,0.6160699889798935
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,0.46991740909360363,0.6176082861117267
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,0.48720847579485366,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,0.4773095607144445,
SAS2015_AZD/DMSO_Exp1,0.4646103046379982,0.6029633151015779
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,0.610400657463061
HS2024_3_B_T3,0.4867452092140388,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,0.6309346075237593
PG2020_Intensity 2h_D,,
EP2017_Untreated R#3 normalized log2 ratio,0.5162019584986152,0.581956098973388
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.47000713538611766,0.6154789297961808
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,,0.5968957660759412
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,0.4646924767867105,0.6287771857765313
EP2017_Pervanadate R#2 normalized log2 ratio,0.514015189238441,0.5986939538303642
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,,0.6308075837629419
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,0.4839383253839901,
KBE2022_Log2_Ex_29_T,0.46017291531094634,0.5903663371924608
HS2024_7_I_T2,0.48986713453992003,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,0.6130630579392027
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,0.49839582782188563,0.6084423558914109
EJN2021_1_Ex_Basal,,
FR2021_Intensity.M,,0.5818133381304943
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,0.48399369085083466,0.6381094675726928
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,,
PG2020_Intensity CT_C,,0.5764566671419832
ZCP2016_Ratio H/L Rep 1,0.4872091632169716,0.517660204391767
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,,
EP2017_Untreated R#3 log2 ratio,0.5168506393169706,0.5833277954172056
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,,0.609521820393773
HS2024_8_PD_T2,0.46615836235732205,
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,0.5565997802954789
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,0.6116417590165304
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,,0.6245486975708407
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,,
YA2020_Reporter_intensity_Normal_No.2,,0.61217989293358
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,0.47670700863123905,
HS2024_3_PD_T3,,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,0.4571232184600382,0.6064559006815086
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,0.4729952146214922,0.5753660947741487
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,,
CK2022_2 16-1,,0.6070947266715306
RAM2015_Log2 B,0.45759325247110577,0.6184503297073282
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,0.4873864911780236,0.5953080967088746
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,0.5925588605315584
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,0.5994677547866865
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,0.48774802384824684,
PG2020_Intensity Mock_10h_B,,0.5645659732678304
WZ2023_Su_025_30min,0.45495534305519225,0.614228705925189
AH2018_LFQ_4_N,,0.6342995684275887
CR2017_Ratio Replicate 1.2,,0.6316487812285752
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,,0.6109603532791096
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,,
AH2018_SILAC_M_1_X,,0.6273236146342358
RB2022_7_PreEndurance,,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,0.4705798726023859,
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,,0.6152796620522964
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,0.6019121462601082
HS2024_5_I_T2,0.4773424389721738,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,0.6031022332974907
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,0.4676759123782434,0.6201424958803544
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,0.47617095638429735,0.6131887760668148
RM2024_Intensity D0-1,,0.5794973068049536
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,,0.6213574473826659
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,0.4732163096454463,
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,,0.6383263720088783
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,,
AH2018_LFQ_2_X,0.46445032557501975,0.6433524493595566
PG2020_Intensity 2h_B,,0.5778371458936921
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,0.47187024460247756,0.5951470410445021
GF2025_P3_Sph,,
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,0.5910556636050104
AH2018_SILAC_1_C,,0.6248868098021528
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,,0.635335311503158
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,0.4525224157807835,0.6147545970374291
CR2017_Ratio Replicate 2.4,,0.5801494621184629
ZQ2022_N1,,
LY2019_P6-,0.4614580353519152,
RM2024_Intensity D2-3,,0.5939050403643795
UK2020_HCM_1,,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,0.5753583269833491
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,0.4824750251923438,0.585230428719991
AH2018_LFQ_3_N,0.4599859941446862,0.6380103106430928
RKK2015_TNF-α/IKKb,,0.6135294555409518
SFR2015_HL_log2_ratio_std_b,0.4976682056521205,0.6156787493037632
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,0.4924742839592217,0.5926687629006326
CK2022_7 40-1,,0.5844480582385557
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,,0.5710632645418173
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,0.48348551266424067,0.5937162153865467
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,,0.5870523767008022
WZ2023_Su_025_20min,0.4477953703029557,0.6145498758866239
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,0.6100752154269846
LY2019_P8-,0.4937002960375336,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,,0.6329580383846543
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,,0.5891481272453962
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,0.600144117721791
PG2020_Intensity 10h_D,,
RB2022_8_PreEndurance,,
HS2024_3_B_N2,,
EJN2021_4_Ex_Ins,,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,
EP2017_Pervanadate R#3 log2 ratio,0.5214364987790868,0.6063676589968121
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,0.48407045027843737,0.6334916670887207
AH2018_LFQ_M_4_C,0.46566151040630654,0.6412563789149187
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,0.601560143534552
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,,0.6025130666348985
CK2022_6 40-1,,0.585160188580177
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,,
LY2019_P3-,0.4792572932340189,
FR2021_Intensity.A,,0.5740927202454579
EJN2021_3_Ex_Ins,,
MV2014_Ratio M/L normalized A1___1 (2 min),,0.6041035604895648
WZ2023_Pe_005_30min,0.46585191336916953,0.6131829074363242
HS2024_8_PD_T3,0.4878168090196458,
EJN2021_3_Ex_Basal,,
AST2020_Control.1,,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,,0.5783919799785806
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.44471100857312645,0.614606635761537
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,,0.6336343546641732
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,0.5747003543216718
HS2024_5_B_N1,,0.5833405940932066
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,0.47575003325090626,0.6477444682248784
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,0.4694466106670386,0.6265107746964866
HS2024_8_I_N2,,0.5788937254171195
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,,0.6267076201010927
LY2019_P8+,0.49601686511819487,
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,0.45496242788091645,0.6221188251225626
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,0.4581047164180888,0.6374766540519452
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,,
LY2019_P2-,0.49299765044693045,
AH2018_LFQ_IT_1_X,,0.6269658169319409
JJ2018_Ratio H/L normalized pP3___1,0.49260363772846094,0.5923956167629928
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,0.4587844564892443,0.6136464101548205
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,0.4906983956797772,0.6597334073076485
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,,0.5841390151748231
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,,
HS2024_5_B_T2,0.47596884963451735,
HS2024_6_I_T1,0.47985205395112407,
HS2024_5_B_T3,0.4831994334642182,
JJ2018_Ratio H/M normalized pP1___1,0.4829712197412146,0.6262715582993449
KBE2022_Log2_Ex_36_U,0.464579635970949,0.589683756491558
AH2018_TMTMS3_3_N,0.4703810176316746,0.6356070816807211
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,0.574708832770711
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,0.4825513755597695,0.6370470139159456
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.5268139371822511,0.713477810581095
KBE2022_Log2_Ex_36_T,0.46481254021262813,0.5848716518158261
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.4582928839442157,0.612075798480428
KS2014_Intensity C2,0.4712835358112506,0.5973337315360265
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,,
CK2022_9 200-1,0.4641511252277883,0.6165597930661797
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,0.4642386249212231,0.6161845570334676
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,0.4678617608829708,
RBK2021_1332T Late,,
LY2019_P1-,0.47714867480925083,
RKK2015_TNF-α/basal.1,,0.6118539266889758
RKK2015_TNF-α/TNF-α+SC-514,,0.615494528671363
CR2017_Ratio Replicate 2.5,,0.6193841278825174
HS2024_3_I_T3,0.4728805183429018,0.6600913200937424
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,0.4686317324176948,0.6105516263305141
ZQ2022_C3,,
EJN2021_3_Rest_Ins,,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,,
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.4889980888276793,0.5223332680223202
RKK2015_SC-514/basal,,0.5871212924273966
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.4464732435957061,0.613685299780501
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,0.4789030376341322,
KS2014_Intensity N1,0.485109718213627,0.6483446321400607
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,0.4511444532366277,0.5994357995935441
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,0.48735714701137545,0.5953205871849059
AH2018_SILAC_MR_2_C,0.4537233632293294,0.6348352977008099
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,,0.5932927218255031
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,0.45800340259095534,0.6409918149381192
JJ2018_Ratio H/M normalized___1,0.4887469737598201,0.610672509025757
RCJD2014_15min_2,,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,0.5935553513470138
HS2024_5_B_N2,,0.635565515818268
HS2024_5_I_N1,,0.6033781392407349
HS2024_6_I_N1,,
AR2021_KD 48h,,0.6177685184385041
FR2021_Intensity.B,,0.5787255183199548
RB2022_3_PreEndurance,,
HS2024_5_I_T1,0.48519976890976146,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,,
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.4601707946009847,0.613222584808477
KBE2022_Log2_Ex_29_U,0.4620800677379468,0.5926606803360828
HS2024_7_B_T1,0.4650541949764159,
AH2018_LFQ_M_2_X,0.4708982046017601,0.6472196673208164
AH2018_LFQ_IT_4_N,,0.6339179254304002
CK2022_15 200-1,0.4627516257686991,0.6173903094336309
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,0.4887074750924502,0.6109279703071512
JJ2018_Ratio M/L normalized pP3___1,0.4817905213878708,0.6163709391452631
KBE2022_Log2_Ex_34_T,0.46259507950972273,0.5910745485968568
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,0.4745244494847049,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,0.4672536987469948,0.6143879242672214
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.45299604828425216,0.6144272520399368
RN2012_H01,,0.6143814308917152
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,0.6059832384663094
EP2017_Pervanadate R#1 normalized log2 ratio,0.521140238730827,0.5766570666600891
HS2024_8_B_T3,,0.5985863417912747
YA2020_Reporter_intensity_Cancer_No.3,,0.6140549307814254
KBE2022_Log2_Ex_44_U,0.46664787502545696,0.5942593832864266
WZ2023_Pe_010_20min,0.46089276699217974,0.612796784354368
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,,
KS2014_Intensity C1,0.4476631414061906,0.6120764749269544
FSO2013_Ratio H/M normalized Rep3___1,,0.6121041546554264
AH2018_SILAC_M_3_C,,0.6308818187930119
RKK2015_TNF-α+IKKb/TNF-α,,0.5832291183420317
RM2024_Intensity D0-3___2,,0.5795021682477968
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,,0.6311813733147105
AH2018_SILAC_M_2_X,,0.631629606188959
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.4490705298397458,0.6142244293121969
PG2020_Intensity 6h_C,,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,0.45193039075783925,0.6144799799354648
AH2018_LFQ_M_3_N,0.466208754066487,0.6421069571530691
VOI2024_0.1uM 24 h_2 mono,,0.6106738120413502
AH2018_TMTMS2_3_C,0.47349996592875104,0.653003504505315
CK2022_15 16-1,,0.6102697795328293
CK2022_3 16-1,,0.611282111701831
LY2019_P4-,0.47816504652453423,
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,,
GF2025_P8_Adh,,0.6307561880552777
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,0.45273857678498197,0.6340258743187583
GF2025_P5_Sph,,
CK2022_10 16-1,,0.6053606759367641
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,0.4771096767696649,0.6133870929427643
IMM2018_normalised rep. int. CDK5L-1,,0.6087461213182653
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.5368825002207306,0.7054720845000142
EJN2021_2_Ex_Basal,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,,0.5924459107958295
AR2021_L41 10 μM,,0.6164673029129266
CF2017_EOC 2,,0.5846086011962046
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,,0.6275112866948307
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,
CK2022_6 16-1,,0.6065006180946072
ZX2022_CB treated Replicate 1,,
BS2014_Log2(Ratio H/L normalized Rep_3),,0.6651956138457205
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,,
RM2024_Intensity D2-2___2,,0.5991556199905197
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.476053484076024,0.6484075119596119
AR2021_L41 1 μM,,0.6034604772186465
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.4707058103498109,0.6430131746500626
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,,
KS2014_Intensity C4,0.4805713239750911,0.6074753681466696
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,0.46433713242719393,0.5959137203202787
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,0.49907504170112116,
SAS2015_PLX/DMSO_Exp3,0.48408959199334894,0.6019027172384283
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,0.4631758928870638,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,,0.6159394356566992
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,,0.6288865546859465
WZ2023_Pu_025_10min,0.4551858441196996,0.6117074619230335
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,
FSO2013_Ratio M/L normalized Rep3___1,,
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,0.4760322353116753,
CF2017_EOC 4,,0.6042728780245294
JJ2018_Ratio H/L normalized pP1___1,0.46214751713857877,0.6235048679178556
WZ2023_Pe_010_30min,0.45994083555594434,0.612770678186797
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,,0.6334570579164591
KS2014_Intensity C6,0.4746417436132678,0.6057839909874467
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,,0.5844401951966415
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,,
JJ2018_Ratio H/M normalized pP1,0.4833339516114893,0.6263972351437348
CK2022_16 40-1,,0.5873062392757731
AH2018_SILAC_IT_2_C,,0.6283638929500249
CK2022_5 40-1,,0.5857071563580606
AH2018_LFQ_3_X,0.4610311226531932,0.6391219685587282
UK2020_UA_3,,
LY2019_P7-,0.48537013834723153,
GF2025_P5_Adh,,
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,,0.5900201169953183
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,,0.6320101225864386
VOI2024_0.1uM 2 h_1 mono,,0.6053539341893426
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,,0.6084067934434539
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,0.5121437817045092,0.6238968302491822
PG2020_Intensity CT_B,,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,0.48371809175904346,0.6416771095991305
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,,
AH2018_LFQ_3_C,,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,0.46696247870477997,0.6431289929672004
YA2020_Reporter_intensity_Cancer_No.4,,0.6169015371902193
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,,
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,0.46228488115749605,0.5889584291196128
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,0.4850559292962496,0.5995470870024631
FR2021_Intensity.H,,0.5844730351228844
CK2022_14 16-1,,0.6103450916020459
AST2020_anti-CD3+PDL2,,
MV2014_Ratio M/L normalized B1___1 (5 min),,0.5695485600696581
KBE2022_Log2_Ex_19_T,,
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,0.46221808588603824,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,0.513046339495151,0.6884180279470762
AH2018_TMTMS2_1_X,0.4760771522185843,0.6478518998260481
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,0.49720400967339357,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,
HS2024_6_I_N2,,
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,,
HS2024_4_I_T3,0.4823020035249848,
AH2018_SILAC_1_X,,0.626917867017345
PG2020_Intensity 10h_B,,
AH2018_TMTMS3_1_X,0.46398083290551334,0.6096197600523262
CF2017_FTE 14,,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,0.5777181193438305
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,,
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,,
EP2017_Untreated R#2 normalized log2 ratio,0.4406419622125209,0.5295303949776952
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,0.4808498250082089,
HS2024_5_I_N2,,0.6045122129851995
SAS2015_PLX/AZD_Exp3,0.4607971688799618,0.6350274016308707
EP2017_Pervanadate R#2 log2 ratio,0.5146369427731239,0.600743141643636
AS2011_Ratio H/L Normalized RNAi_2_1,,
